AIC
NVO

Aurora Investment Counsel’s Novo Nordisk NVO Stock Holding History

Aurora Investment Counsel’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Sell
44,484
-1,397
-3% -$60K 1.1% 38
2026
Q1 		$1.69M Buy
45,881
+1,496
+3% +$70.9K 0.94% 55
2025
Q4 		$2.26M Buy
44,385
+5,706
+15% +$292K 1.19% 36
2025
Q3 		$2.15M Buy
38,679
+9,419
+32% +$551K 1.12% 39
2025
Q2 		$2.02M Buy
+29,260
New +$1.99M 1.06% 41
2022
Q1 		– Sell
-27,614
Closed -$1.55M – 130
2021
Q4 		$1.55M Sell
27,614
-3,458
-11% -$187K 0.92% 44
2021
Q3 		$1.49M Sell
31,072
-3,020
-9% -$146K 1.04% 36
2021
Q2 		$1.43M Buy
34,092
+266
+0.8% +$10.3K 1% 42
2021
Q1 		$1.14M Buy
33,826
+278
+0.8% +$9.9K 0.84% 62
2020
Q4 		$1.17M Sell
33,548
-16
-0% -$553 0.94% 47
2020
Q3 		$1.12M Sell
33,564
-214
-0.6% -$7.13K 0.92% 47
2020
Q2 		$1.11M Sell
33,778
-4,180
-11% -$133K 1.05% 33
2020
Q1 		$1.14M Sell
37,958
-4,408
-10% -$131K 1.26% 15
2019
Q4 		$1.23M Sell
42,366
-19,848
-32% -$550K 0.92% 46
2019
Q3 		$1.61M Sell
62,214
-1,430
-2% -$36.2K 0.78% 71
2019
Q2 		$1.52M Buy
63,644
+4,234
+7% +$105K 0.73% 83
2019
Q1 		$1.55M Buy
+59,410
New +$1.46M 0.77% 74
2014
Q4 		$1.86M Sell
88,004
-3,030
-3% -$67.7K 1.15% 45
2014
Q3 		$2.17M Sell
91,034
-13,692
-13% -$315K 1.42% 13
2014
Q2 		$2.42M Buy
104,726
+2,950
+3% +$65.1K 1.52% 7
2014
Q1 		$2.32M Sell
101,776
-12,384
-11% -$264K 1.49% 5
2013
Q4 		$2.11M Buy
+114,160
New +$1.99M 1.39% 20

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Aurora Investment Counsel's NVO Position: Q2 2026 in Review

Aurora Investment Counsel reduced its Novo Nordisk (NVO) stake by 3% in Q2 2026, selling an estimated $60K and leaving 44,484 shares worth $2.13M. The position accounts for 1.1% of the portfolio, ranked #38.

Aurora Investment Counsel first reported a position in NVO in Q4 2013 and has held it in 22 quarters since. The position peaked at $2.42M in Q2 2014. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Aurora Investment Counsel held 44,484 shares of Novo Nordisk worth $2.13M as of Q2 2026.
  • Aurora Investment Counsel sold 1,397 Novo Nordisk shares in Q2 2026, an estimated $60K.
  • Novo Nordisk made up 1.1% of Aurora Investment Counsel's portfolio in Q2 2026, its #38 holding.
  • Aurora Investment Counsel first reported a position in Novo Nordisk in Q4 2013 and has held it in 22 quarters since.
  • Aurora Investment Counsel's Novo Nordisk position peaked at $2.42M in Q2 2014.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Aurora Investment Counsel's 13F filing for Q2 2026, filed 10 Aug 2026.